Abstract
The protein C anticoagulant pathway serves as a vitally important system limiting the coagulation response. The pathway is triggered by thrombin allowing the trombin-thrombomodulin (TM)-endothelial protein C receptor (EPCR) complex to activate protein C. The discovery of the protein C pathway and genetic defects affecting the system in relation to the risk of venous thrombosis directed most research attention towards its anti-coagulatory properties. The observation that activated protein C (APC) has potentially important functions in controlling inflammation and functioning as a natural defence against sepsis, redirected research into its cellular functions. Intracellular signaling effects in endothelial cells induced by APC depend on the presence of the endothelial protein C receptor and protease activated receptor-1 and involves a variety of distinct signal transduction pathways engaged in various biological activities. However, the exact mechanism by which the protein C pathway controls inflammation during sepsis and to what extend the signaling capacity of APC contributes to its pro-survival effects remains elusive. Other essential factors of the protein C pathway, like EPCR and TM may themselves be directly involved in regulating inflammation, underlining the importance of the complete pathway. © 2005 Bentham Science Publishers Ltd.
| Original language | English |
|---|---|
| Pages (from-to) | 405-410 |
| Journal | CURRENT GENOMICS |
| Volume | 6 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Oct 2005 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Perspectives of activated protein C in the vasculature: Update on proposed roles of the protein C pathway'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver